Allworth Financial
LRMR icon

Allworth Financial’s Larimar Therapeutics LRMR Stock Holding History

Allworth Financial’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Buy
4,388
+2,866
+188% +$11.4K ﹤0.01% 3518
2026
Q1 		$6.85K Buy
1,522
+1,521
+152,100% +$6.08K ﹤0.01% 3759
2025
Q4 		$4 Sell
1
-358
-100% -$1.39K ﹤0.01% 4988
2025
Q3 		$1.16K Buy
+359
New +$1.35K ﹤0.01% 4206
2023
Q2 		– Sell
-13
Closed -$59 – 3326
2023
Q1 		$59 Buy
+13
New +$68 ﹤0.01% 3118

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Allworth Financial's LRMR Position: Q2 2026 in Review

Allworth Financial increased its Larimar Therapeutics (LRMR) stake by 188% in Q2 2026, buying an estimated $11.4K and bringing the position to 4,388 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3518.

Allworth Financial first reported a position in LRMR in Q1 2023 and has held it in 5 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Allworth Financial held 4,388 shares of Larimar Therapeutics worth $13.4K as of Q2 2026.
  • Allworth Financial bought 2,866 Larimar Therapeutics shares in Q2 2026, an estimated $11.4K.
  • Larimar Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3518 holding.
  • Allworth Financial first reported a position in Larimar Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.